NAD+ 400mg

NAD+ (nicotinamide adenine dinucleotide) is an endogenous dinucleotide coenzyme found across living cells and involved in a broad range of biochemical processes. NAD+ is supplied as a laboratory reference material for metabolic, cellular and redox research programmes.

Research involving NAD+ commonly examines redox chemistry, cellular energy metabolism and enzyme-dependent reactions in which NAD+ participates as a cofactor. It can therefore be relevant to experimental models investigating mitochondrial function, metabolic signalling and cellular responses to changes in redox state. These are research contexts, not statements that the product produces a particular outcome in humans.

The listed 400mg presentation should be interpreted according to the current product specification. Researchers should verify the exact quantity, analytical documentation and batch information before procurement or experimental use.

Each batch is supplied with a Certificate of Analysis (COA) from independent third-party testing, covering HPLC purity and mass-spectrometry identity. Batch-level documentation can be used to support laboratory records and procurement traceability.

For reproducibility, researchers should document the compound identity, batch, storage conditions, preparation method and experimental concentration. Any stability considerations should be assessed against the manufacturer's current documentation and the requirements of the laboratory protocol.

NAD+ 400mg is for laboratory research use only. It is not a medicinal product, is not licensed by the MHRA and is not intended for human or veterinary use, diagnosis, treatment or self-administration. Sold only to qualified researchers aged 18 or over.